WHITE MATTER INJURY

Clinical trials for WHITE MATTER INJURY explained in plain language.

Never miss a new study

Get alerted when new WHITE MATTER INJURY trials appear

Sign up with your email to follow new studies for WHITE MATTER INJURY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Common allergy drug may heal brain damage in preterm infants

Disease control Not yet recruiting

This study tests whether clemastine, an allergy medicine, is safe for premature babies with white matter injury—a common brain injury in infants born early. Researchers will give the drug by mouth to 24 babies born at or before 32 weeks and now between 35 and 41 weeks old. The go…

Matched conditions: WHITE MATTER INJURY

Phase: PHASE1 • Sponsor: Bridget LaMonica Ostrem, M.D., Ph.D. • Aim: Disease control

Last updated Jul 09, 2026 00:00 UTC

WHITE MATTER INJURY

Get alerted when new WHITE MATTER INJURY trials appear

Common allergy drug may heal brain damage in preterm infants